The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer

Published:2021-01-18 Issue:2 Volume:27 Page:310-320
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Hickey Theresa E.^ORCID,Selth Luke A.,Chia Kee Ming,Laven-Law Geraldine^ORCID,Milioli Heloisa H.^ORCID,Roden Daniel^ORCID,Jindal Shalini,Hui Mun,Finlay-Schultz Jessica^ORCID,Ebrahimie Esmaeil^ORCID,Birrell Stephen N.^ORCID,Stelloo Suzan,Iggo Richard^ORCID,Alexandrou Sarah^ORCID,Caldon C. Elizabeth^ORCID,Abdel-Fatah Tarek M.,Ellis Ian O.,Zwart Wilbert^ORCID,Palmieri Carlo,Sartorius Carol A.,Swarbrick Alex^ORCID,Lim Elgene^ORCID,Carroll Jason S.^ORCID,Tilley Wayne D.^ORCID

Funder

Department of Health | National Health and Medical Research Council

National Breast Cancer Foundation

Cancer Australia

Hospital Research Foundation

Joint Movember & National Breast Cancer Foundation Collaboration Initiative

U.S. Department of Defense

Royal Adelaide Hospital

University of Adelaide

Cancer Institute NSW

U.S. Department of Health & Human Services | National Institutes of Health

Breast Cancer Research Foundation

Movember Foundation

KWF Kankerbestrijding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Cancer Research UK

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-020-01168-7.pdf

Reference86 articles.

1. Somboonporn, W. & Davis, S. R. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr. Rev. 25, 374–388 (2004).

2. Hickey, T. E., Robinson, J. L., Carroll, J. S. & Tilley, W. D. Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol. Endocrinol. 26, 1252–1267 (2012).

3. Goldenberg, I. S. Testosterone propionate therapy in breast cancer. JAMA 188, 1069–1072 (1964).

4. Kennedy, B. J. Fluoxymesterone therapy in advanced breast cancer. N. Engl. J. Med. 259, 673–675 (1958).

5. Jordan, V. C. & Brodie, A. M. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids 72, 7–25 (2007).

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extra-nuclear and cytoplasmic steroid receptor signalling in hormone dependent cancers;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtype;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

3. Androgen receptor expression and clinical characteristics in breast cancer;World Journal of Surgical Oncology;2024-09-11

4. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment;Drug Resistance Updates;2024-09

5. The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3